Us & Global Director, Paxlovid, Business Analytics & Insights
Current• Developed and led US & global primary market research plans in support of global marketing launch & commercialization for Paxlovid anti-viral franchise. Responsible for managing Paxlovid PMR plans with budget >$8M.• Represented BAI team to partner with Paxlovid marketing leaders and develop franchise operating plans, forecasting, secondary analytics plans and brand strategy• Led BAI global launch strategy for novel diagnostics device, Lucira by Pfizer